Skip to main content
PMC home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1984 Dec 1;160(6):1767–1781. doi: 10.1084/jem.160.6.1767

Pathogenesis of Shigella diarrhea. IX. Simplified high yield purification of Shigella toxin and characterization of subunit composition and function by the use of subunit-specific monoclonal and polyclonal antibodies

PMCID: PMC2187538  PMID: 6392471

Abstract

A simple purification scheme for shigella cytotoxin was devised, resulting in high yields (approximately 50%) and a 1,300-fold increase in specific activity compared with the initial crude bacterial cell lysate. The purified toxin was enterotoxic in ligated rabbit ileal loops and neurotoxic when injected into the peritoneal cavity of mice. Measurement of specific activity of cytotoxin and enterotoxin demonstrated that these two toxicities copurify during the fractionation procedure. On sodium dodecyl sulfate gel electrophoresis, the toxin migrated as two polypeptide subunits, an A subunit of 32,000 mol wt and a B subunit of 6,500 mol wt. Chemical cross-linking experiments demonstrate that the toxin is a complex consisting of one A and five B subunits with a molecular weight of 64,000. Polyclonal rabbit anti-toxin and anti-subunit B antisera were produced as well as subunit-specific mouse monoclonal antibodies. All antibodies preincubated with toxin neutralized cytotoxic effects in HeLa cell monolayers. In contrast, only A subunit-specific antibodies were able to neutralize toxin prebound to the HeLa cell surface. Antibody to the B subunit also inhibited binding of 125I-labeled toxin to these cells by 94% or more. These data demonstrate that the B subunit is involved in shigella toxin binding to the cell surface.

Full Text

The Full Text of this article is available as a PDF (969.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brew K., Shaper J. H., Olsen K. W., Trayer I. P., Hill R. L. Cross-linking of the components of lactose synthetase with dimethylpimelimidate. J Biol Chem. 1975 Feb 25;250(4):1434–1444. [PubMed] [Google Scholar]
  2. Burnette W. N. "Western blotting": electrophoretic transfer of proteins from sodium dodecyl sulfate--polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A. Anal Biochem. 1981 Apr;112(2):195–203. doi: 10.1016/0003-2697(81)90281-5. [DOI] [PubMed] [Google Scholar]
  3. Dharmalingam K., Goldberg E. B. Restriction in vivo. III. General effects of glucosylation and restriction on phage T4 gene expression and replication. Virology. 1979 Jul 30;96(2):393–403. doi: 10.1016/0042-6822(79)90097-7. [DOI] [PubMed] [Google Scholar]
  4. Dubos R. J., Geiger J. W. PREPARATION AND PROPERTIES OF SHIGA TOXIN AND TOXOID. J Exp Med. 1946 Jul 31;84(2):143–156. [PMC free article] [PubMed] [Google Scholar]
  5. Eiklid K., Olsnes S. Animal toxicity of Shigella dysenteriae cytotoxin: evidence that the neurotoxic, enterotoxic, and cytotoxic activities are due to one toxin. J Immunol. 1983 Jan;130(1):380–384. [PubMed] [Google Scholar]
  6. Finkelstein R. A., Atthasampunna P., Chulasamaya M., Charunmethee P. Pathogenesis of experimental cholera: biologic ativities of purified procholeragen A. J Immunol. 1966 Mar;96(3):440–449. [PubMed] [Google Scholar]
  7. HUNTER W. M., GREENWOOD F. C. Preparation of iodine-131 labelled human growth hormone of high specific activity. Nature. 1962 May 5;194:495–496. doi: 10.1038/194495a0. [DOI] [PubMed] [Google Scholar]
  8. Jacewicz M., Keusch G. T. Pathogenesis of Shigella diarrhea. VIII. Evidence for a translocation step in the cytotoxic action of Shiga toxin. J Infect Dis. 1983 Nov;148(5):844–854. doi: 10.1093/infdis/148.5.844. [DOI] [PubMed] [Google Scholar]
  9. Kessler S. W. Rapid isolation of antigens from cells with a staphylococcal protein A-antibody adsorbent: parameters of the interaction of antibody-antigen complexes with protein A. J Immunol. 1975 Dec;115(6):1617–1624. [PubMed] [Google Scholar]
  10. Keusch G. T., Donohue-Rolfe A., Jacewicz M. Shigella toxin(s): description and role in diarrhea and dysentery. Pharmacol Ther. 1981;15(3):403–438. doi: 10.1016/0163-7258(81)90052-8. [DOI] [PubMed] [Google Scholar]
  11. Keusch G. T., Grady G. F., Mata L. J., McIver J. The pathogenesis of Shigella diarrhea. I. Enterotoxin production by Shigella dysenteriae I. J Clin Invest. 1972 May;51(5):1212–1218. doi: 10.1172/JCI106915. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Keusch G. T., Grady G. F., Takeuchi A., Sprinz H. The pathogenesis of shigella diarrhea. II. Enterotoxin-induced acute enteritis in the rabbit ileum. J Infect Dis. 1972 Jul;126(1):92–95. doi: 10.1093/infdis/126.1.92. [DOI] [PubMed] [Google Scholar]
  13. Keusch G. T., Jacewicz M., Hirschman S. Z. Quantitative microassay in cell culture for enterotoxin of Shigella dysenteriae. J Infect Dis. 1972 May;125(5):539–541. doi: 10.1093/infdis/125.5.539. [DOI] [PubMed] [Google Scholar]
  14. Keusch G. T., Jacewicz M. Pathogenesis of Shigella diarrhea. VII. Evidence for a cell membrane toxin receptor involving beta1 leads to 4-linked N-acetyl-D-glucosamine oligomers. J Exp Med. 1977 Aug 1;146(2):535–546. doi: 10.1084/jem.146.2.535. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Keusch G. T., Jacewicz M. Primary amines and chloroquine inhibit cytotoxic responses to Shigella toxin and permit late antibody rescue of toxin treated cells. Biochem Biophys Res Commun. 1984 May 31;121(1):69–76. doi: 10.1016/0006-291x(84)90689-2. [DOI] [PubMed] [Google Scholar]
  16. Keusch G. T., Jacewicz M. Serum enterotoxin-neutralizing antibody in human shigellosis. Nat New Biol. 1973 Jan 3;241(105):31–32. doi: 10.1038/newbio241031a0. [DOI] [PubMed] [Google Scholar]
  17. Keusch G. T., Jacewicz M. The pathogenesis of Shigella diarrhea. VI. Toxin and antitoxin in Shigella flexneri and Shigella sonnei infections in humans. J Infect Dis. 1977 Apr;135(4):552–556. doi: 10.1093/infdis/135.4.552. [DOI] [PubMed] [Google Scholar]
  18. Köhler G., Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature. 1975 Aug 7;256(5517):495–497. doi: 10.1038/256495a0. [DOI] [PubMed] [Google Scholar]
  19. Levine M. M., Black R. E., Clements M. L., Young C. R., Lanata C., Sears S., Honda T., Finkelstein R. Texas Star-SR: attenuated "Vibrio cholerae" oral vaccine candidate. Dev Biol Stand. 1983;53:59–65. [PubMed] [Google Scholar]
  20. O'Brien A. D., Chen M. E., Holmes R. K., Kaper J., Levine M. M. Environmental and human isolates of Vibrio cholerae and Vibrio parahaemolyticus produce a Shigella dysenteriae 1 (Shiga)-like cytotoxin. Lancet. 1984 Jan 14;1(8368):77–78. doi: 10.1016/s0140-6736(84)90006-0. [DOI] [PubMed] [Google Scholar]
  21. O'Brien A. D., LaVeck G. D., Griffin D. E., Thompson M. R. Characterization of Shigella dysenteriae 1 (Shiga) toxin purified by anti-Shiga toxin affinity chromatography. Infect Immun. 1980 Oct;30(1):170–179. doi: 10.1128/iai.30.1.170-179.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. O'Brien A. D., LaVeck G. D. Purification and characterization of a Shigella dysenteriae 1-like toxin produced by Escherichia coli. Infect Immun. 1983 May;40(2):675–683. doi: 10.1128/iai.40.2.675-683.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. O'Brien A. D., LaVeck G. D., Thompson M. R., Formal S. B. Production of Shigella dysenteriae type 1-like cytotoxin by Escherichia coli. J Infect Dis. 1982 Dec;146(6):763–769. doi: 10.1093/infdis/146.6.763. [DOI] [PubMed] [Google Scholar]
  24. O'Brien A. D., Thompson M. R., Gemski P., Doctor B. P., Formal S. B. Biological properties of Shigella flexneri 2A toxin and its serological relationship to Shigella dysenteriae 1 toxin. Infect Immun. 1977 Mar;15(3):796–798. doi: 10.1128/iai.15.3.796-798.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Olsnes S., Eiklid K. Isolation and characterization of Shigella shigae cytotoxin. J Biol Chem. 1980 Jan 10;255(1):284–289. [PubMed] [Google Scholar]
  26. Olsnes S., Reisbig R., Eiklid K. Subunit structure of Shigella cytotoxin. J Biol Chem. 1981 Aug 25;256(16):8732–8738. [PubMed] [Google Scholar]
  27. Reisbig R., Olsnes S., Eiklid K. The cytotoxic activity of Shigella toxin. Evidence for catalytic inactivation of the 60 S ribosomal subunit. J Biol Chem. 1981 Aug 25;256(16):8739–8744. [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES